Special Drug Use Investigation for ALLERMIST (Long Term)

GlaxoSmithKline (GSK)

Status: Completed

Conditions: Rhinitis

Treatments: Drug: Fluticasone

Study type: Observational

Funder types: Industry

Identifiers

NCT01420822

113406

Details and patient eligibility

About

This post-marketing surveillance study is to investigate possible problems or questions in safety and efficacy of ALLERMIST Nasal Spray for long-term use in Japanese subjects with allergic rhinitis under the conditions of actual practical use.

Enrollment: 500 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosis of allergic rhinitis
• Use ALLERMIST for the first time
• Expected to use ALLERMIST for long-term (1 year).

Exclusion criteria

• Subjects with infection which fluticasone is not effective
• Subjects with deep mycosis
• Subjects with hypersensitivity to fluticasone

Trial design

500 participants in 1 patient group

Subjects prescribed ALLERMIST

Description:

Subjects with allergic rhinitis prescribed ALLERMIST during study period

Treatment:

Drug: Fluticasone